FDA grants fast track status to Oncolytics' pelareorep for anal cancer
Go back to FDA grants fast track status to Oncolytics' pelareorep for anal cancer| Oncolytics Biotech, Inc. (NASDAQ: ONCY) | Delayed: 0.83 -0.02 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.85 | 52 Week High | $1.37 | |||
| Open | $0.83 | 52 Week Low | $0.24 | |||
| Day High | $0.84 | P/E | N/A | |||
| Day Low | $0.81 | EPS | $0.00 | |||
| Volume | 285,750 | |||||
